BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 991653)

  • 1. Comprehensive therapy of the schizophrenic syndrome.
    Cancro R
    Curr Psychiatr Ther; 1976; 16():91-100. PubMed ID: 991653
    [No Abstract]   [Full Text] [Related]  

  • 2. Classification of neuroleptics based on their pharmacokinetics.
    Dahl SG
    Clin Neuropharmacol; 1986; 9 Suppl 4():409-11. PubMed ID: 2882845
    [No Abstract]   [Full Text] [Related]  

  • 3. Simplified symptom registration in psychiatric trials: a statistical approach.
    Hansen V; Hagen AS; Lehmann EH; Astrup C
    Acta Psychiatr Scand; 1974; 50(5):492-5. PubMed ID: 4156625
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of trifluperidol (R 2498) on the urinary elimination of bufotenin in schizophrenia.
    Acebal EM; Spatz H
    Int J Neuropsychiatry; 1967 Dec; 3(6):472-6. PubMed ID: 5583441
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical results with trifluoperidol in schizophrenic patients].
    Navarro MP; Assis LM; Martins C
    Rev Assoc Med Bras; 1966 Dec; 12(12):497-501. PubMed ID: 5241539
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of schizophrenic patients with triperidol (trisedil)].
    Ezhkov AA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(9):1394-400. PubMed ID: 5705722
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacotherapy of schizophrenia.
    Klerman GL
    Annu Rev Med; 1974; 25(0):199-217. PubMed ID: 4152997
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapy of schizophrenia].
    Tölle R
    Dtsch Med Wochenschr; 1968 Jun; 93(23):1155-7. PubMed ID: 5648363
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of schizophrenic states with a new long-acting tranquilizer].
    Buisson JF
    Ann Med Psychol (Paris); 1973 Feb; 2(2):287-93. PubMed ID: 4749248
    [No Abstract]   [Full Text] [Related]  

  • 10. [Action of flupentixol decanoate in chronic psychoses of the schizophrenic type].
    Evrard E; Heusghem C; Molders V; Plomteux G; Lebas A
    Acta Psychiatr Belg; 1972 Sep; 72(5):573-94. PubMed ID: 4669430
    [No Abstract]   [Full Text] [Related]  

  • 11. Options for treatment of the schizophrenic patient.
    Lehmann H
    Can Ment Health; 1976 Mar; 24(1):3-9. PubMed ID: 1023999
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparison of triperidol with perphenazine in schizophrenic psychoses. Effect on the photomyoclonic threshold].
    Náhunek K; Hádlík J; Rodová A; Misurec J; Vanýsek J
    Act Nerv Super (Praha); 1970 Jan; 12(1):56-7. PubMed ID: 4907390
    [No Abstract]   [Full Text] [Related]  

  • 13. [Principles of a differentiated treatment of schizophrenia using psychotropic agents].
    Awruzkij GJ
    Psychiatr Neurol Med Psychol (Leipz); 1966 Dec; 18(12):459-61. PubMed ID: 5983906
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative study of trifluperidol and trifluoperazine in the treatment of acute schizophrenia].
    Gauthier R; Hillel J; Bordeleau JM; Tétreault L
    Union Med Can; 1967 Aug; 96(8):936-43. PubMed ID: 5618135
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of the schizophrenic patient in a community psychiatric practice.
    Tobin JM
    Dis Nerv Syst; 1968 May; 29(5):Suppl:27-34. PubMed ID: 4876987
    [No Abstract]   [Full Text] [Related]  

  • 16. Thymosthenic agents, a novel approach in the treatment of schizophrenia.
    Gelders YG
    Br J Psychiatry Suppl; 1989 Jul; (5):33-6. PubMed ID: 2481482
    [No Abstract]   [Full Text] [Related]  

  • 17. [Acute drug-induced extrapyramidal syndrome: case studies of a decade at the autonomous toxicology department of the Arcispedale].
    Torrini M; Masini E; Ledda F; Mannaioni PF
    Clin Ter; 1981 Jun; 97(6):561-85. PubMed ID: 7023804
    [No Abstract]   [Full Text] [Related]  

  • 18. [Complementary neurolepsy].
    Petrilowitsch N; Herzog R
    Psychiatr Neurol (Basel); 1966; 151(4):195-207. PubMed ID: 5925592
    [No Abstract]   [Full Text] [Related]  

  • 19. Conditions in adolescents who were borderline psychotics as children. Three cases illustrating diagnostic and therapeutic problems.
    Aarkrog T
    Acta Psychiatr Scand; 1973; 49(4):377-85. PubMed ID: 4746006
    [No Abstract]   [Full Text] [Related]  

  • 20. [Psychodynamic aspects of schizophrenic negativism in individual psychotherapy].
    Benedetti G
    Schweiz Arch Neurol Neurochir Psychiatr; 1984; 135(1):17-27. PubMed ID: 6484530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.